Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Event, Conference Call, Webcast, Advisory

Sage Therapeutics to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023


Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, May 2, 2023 at 8:00 a.m. ET to review first quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage's website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit. www.sagerx.com.


These press releases may also interest you

at 01:00
Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs
The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the development of a new prophylactic vaccine against malaria and a new anti-malarial drug and approximately 273...

at 00:30
World's Deepest Mining Site Trusted Oizom's Real-Time Air Quality Monitors for Maintaining Occupational Health & Safety
In a pivotal move to elevate occupational health, safety, and environmental standards, Oizom has successfully deployed its real-time air quality monitor - Dustroid - at the world's deepest gold undermine South Africa. Oizom is a leading global...

at 00:28
The VasQtm External Support Now FDA Cleared for Use in Creating Arteriovenous Fistulas
Laminate Medical Technologies (Laminate) has announced their flagship device, the VasQ External Vascular Support, has been cleared by the FDA for use to create arteriovenous fistulas (AVFs) for dialysis access. The device, designated by the FDA as a...

at 00:00
HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South
Telix Pharmaceuticals Limited  has welcomed Her Royal Highness, Princess Astrid, Princess of Belgium to Telix Manufacturing Solutions (TMS), the Company's recently inaugurated production facility, in Brussels South (Seneffe) in the Wallonia region of...

26 sep 2023
ARPA-H Selects Pegasus Park in Dallas as a HUB Location for its Newly Established Federal Agency
The 9th Annual BioNTX iC³ Life Science Summit is just two days away, and today's announcement from the newly established federal agency, the Advanced Research Projects Agency for Health (ARPA-H), marks the beginning of an exciting week for the...

26 sep 2023
Celebrate the Newest Treatment at North Texas Plastic Surgery's 'BBL + Bubbly' Party
North Texas Plastic Surgery (NTPS)...

More news about Health...


News published on and distributed by: